192 related articles for article (PubMed ID: 23359252)
1. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.
Goel HL; Sayeed A; Breen M; Zarif MJ; Garlick DS; Leav I; Davis RJ; Fitzgerald TJ; Morrione A; Hsieh CC; Liu Q; Dicker AP; Altieri DC; Languino LR
J Cell Physiol; 2013 Jul; 228(7):1601-9. PubMed ID: 23359252
[TBL] [Abstract][Full Text] [Related]
2. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
Sayeed A; Lu H; Liu Q; Deming D; Duffy A; McCue P; Dicker AP; Davis RJ; Gabrilovich D; Rodeck U; Altieri DC; Languino LR
Oncotarget; 2016 Aug; 7(33):52618-52630. PubMed ID: 27438371
[TBL] [Abstract][Full Text] [Related]
3. IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels.
Sayeed A; Fedele C; Trerotola M; Ganguly KK; Languino LR
PLoS One; 2013; 8(10):e76513. PubMed ID: 24130778
[TBL] [Abstract][Full Text] [Related]
4. Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1.
Goel HL; Underwood JM; Nickerson JA; Hsieh CC; Languino LR
J Cell Physiol; 2010 Jul; 224(1):210-7. PubMed ID: 20333644
[TBL] [Abstract][Full Text] [Related]
5. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor 1 stimulation of androgen receptor activity requires β(1A) integrins.
Sayeed A; Alam N; Trerotola M; Languino LR
J Cell Physiol; 2012 Feb; 227(2):751-8. PubMed ID: 21465482
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
Carapancea M; Cosaceanu D; Budiu R; Kwiecinska A; Tataranu L; Ciubotaru V; Alexandru O; Banita M; Pisoschi C; Bäcklund ML; Lewensohn R; Dricu A
J Neurooncol; 2007 Dec; 85(3):245-54. PubMed ID: 17568996
[TBL] [Abstract][Full Text] [Related]
8. RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.
Broustas CG; Lieberman HB
Prostate; 2014 Oct; 74(14):1359-70. PubMed ID: 25111005
[TBL] [Abstract][Full Text] [Related]
9. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Åberg M; Edén D; Siegbahn A
Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
[TBL] [Abstract][Full Text] [Related]
10. Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer.
Eke I; Makinde AY; Aryankalayil MJ; Reedy JL; Citrin DE; Chopra S; Ahmed MM; Coleman CN
Mol Cancer Res; 2018 Dec; 16(12):1855-1864. PubMed ID: 30042176
[TBL] [Abstract][Full Text] [Related]
11. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
12. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.
Dickreuter E; Eke I; Krause M; Borgmann K; van Vugt MA; Cordes N
Oncogene; 2016 Mar; 35(11):1353-62. PubMed ID: 26073085
[TBL] [Abstract][Full Text] [Related]
13. Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.
Lee YC; Jin JK; Cheng CJ; Huang CF; Song JH; Huang M; Brown WS; Zhang S; Yu-Lee LY; Yeh ET; McIntyre BW; Logothetis CJ; Gallick GE; Lin SH
Mol Cancer Res; 2013 Apr; 11(4):405-17. PubMed ID: 23339185
[TBL] [Abstract][Full Text] [Related]
14. β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy.
Eke I; Deuse Y; Hehlgans S; Gurtner K; Krause M; Baumann M; Shevchenko A; Sandfort V; Cordes N
J Clin Invest; 2012 Apr; 122(4):1529-40. PubMed ID: 22378044
[TBL] [Abstract][Full Text] [Related]
15. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.
Park CC; Zhang HJ; Yao ES; Park CJ; Bissell MJ
Cancer Res; 2008 Jun; 68(11):4398-405. PubMed ID: 18519702
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.
Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
18. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor].
Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931
[No Abstract] [Full Text] [Related]
19. VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer.
Goel HL; Chang C; Pursell B; Leav I; Lyle S; Xi HS; Hsieh CC; Adisetiyo H; Roy-Burman P; Coleman IM; Nelson PS; Vessella RL; Davis RJ; Plymate SR; Mercurio AM
Cancer Discov; 2012 Oct; 2(10):906-21. PubMed ID: 22777769
[TBL] [Abstract][Full Text] [Related]
20. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
